Abiopharma

News list

Yi Sang 🟡 adjusted position in 0 shares (2 derivative) of ZIMMER BIOMET HOLDINGS, INC. (ZBH) Transaction Date: Mar 06, 2026 | Filing ID: 000010

Full text

News bot March 10, 2026, 8:08 p.m.
🔍 Yi Sang (Executive)

Company: ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Report Date: 2026-03-06
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 9,414
- Total shares sold: 9,414
Detailed Transactions and Holdings:
- Acquired 7,050 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 29,887.00 | transaction_form_type: 4
- Acquired 2,364 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 32,251.00 | transaction_form_type: 4
- Sold 7,050 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: M | Expires: 2026-03-06 | Exercise: 2026-03-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,364 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: M | Expires: 2026-03-06 | Exercise: 2026-03-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Each RSU represents a contingent right to receive one share of Company common stock.